No Prescription |
 |
 | ||
|
Daxid Lustral |
|
| ||
No Prescription » Prescription Drugs 5 » Daxid Lustral Sertraline is indicated for the treatment of major depressive disorder in adults.Sertraline is used for: Treating depression obsessive-compulsive disorder (OCD) panic disorder posttraumatic stress disorder (PTSD) premenstrual dysphoric disorder (PMDD; a severe form of premenstrual syndrome) and social anxiety disorder. Sertraline is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). Sertraline affects chemicals in the brain that may become unbalanced and cause depression panic anxiety or obsessive-compulsive symptoms.Sertraline is used to treat depression obsessive-compulsive disorder panic disorder anxiety disorders post-traumatic stress disorder (PTSD) and premenstrual dysphoric disorder (PMDD).Sertraline is prescribed for major depression--a persistently low mood that interferes with everyday living. Symptoms may include loss of interest in your usual activities disturbed sleep change in appetite constant fidgeting or lethargic movement fatigue feelings of worthlessness or guilt difficulty thinking or concentrating and recurrent thoughts of suicide. Buy Daxid Lustral and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Daxid Lustral: Product Type: Prescription Drugs 5 Daxid (Lustral Zoloft Seralin Generic Sertraline) Daxid (Lustral Zoloft Seralin Generic Sertraline) Lustral Zoloft Seralin Generic Sertraline 100mg 100 Tablets 100mg 200(2 x 100) Tablets 100mg 400(4 x 100) Tablets 50mg 100 Tablets 50mg 200(2 x 100) Tablets 50mg 400(4 x 100) Tablets Lustral Zoloft Seralin Generic Sertraline Daxid
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
